Clinical trial
A Trial of Antenatal Treatment of Alloimmune Thrombocytopenia
NCT00194987 · Weill Medical College of Cornell University, Other · Completed
Key facts
| NCT number | NCT00194987 |
|---|---|
| Title | A Trial of Antenatal Treatment of Alloimmune Thrombocytopenia |
| Official title | A Randomized Multicenter Trial of Antenatal Treatment of Alloimmune Thrombocytopenia |
| Lead sponsor | Weill Medical College of Cornell University, Other |
| Collaborators | New York Presbyterian Hospital Columbia University |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Alloimmune Thrombocytopenia, Fetal Alloimmune Thrombocytopenia |
| Intervention type | Drug |
| Interventions | IVIG (Intravenous Immunoglobulin), prednisone |
| Enrollment | 102 |
| Start date | Apr 1, 2001 |
| Primary completion | Jun 30, 2015 |
| Completion | Jun 30, 2015 |
| First posted | Sep 19, 2005 |
| Last update posted | Nov 7, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: